Research in Oncology (RESONCOL) - Keyword Index
Home
Browse
Current Issue
By Issue
By Author
By Subject
Author Index
Keyword Index
Journal Info
About Journal
Aims and Scope
Editorial Board
Publication Ethics
Indexing and Abstracting
Peer Review Process
Guide for Authors
Submit Manuscript
Contact Us
Login
Register
Home
Keyword Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Abd El Bary et al; Volume 15, Issue 1, 2019, Page 38-38
Abemaciclib; Volume 16, Issue 2, 2020, Page 31-34
Acuros XB algorithm; Volume 14, Issue 1, 2018, Page 34-38
Acute leukemia; Volume 18, Issue 1, 2022, Page 29-36
Acute lymphoblastic leukemia; Volume 17, Issue 1, 2021, Page 23-30
Acute lymphoblastic leukemia; Volume 17, Issue 2, 2021, Page 51-59
Acute lymphoblastic leukemia; Volume 18, Issue 2, 2022, Page 61-68
Acute Myeloid Leukemia; Volume 14, Issue 1, 2018, Page 47-49
Acute Myeloid Leukemia; Volume 18, Issue 2, 2022, Page 76-80
Adaptive radiotherapy; Volume 14, Issue 1, 2018, Page 29-33
Adjuvant; Volume 15, Issue 2, 2019, Page 46-52
Advanced cancer; Volume 13, Issue 2, 2017, Page 51-55
Africa; Volume 14, Issue 1, 2018, Page 2-5
Allogeneic stem cell transplant; Volume 14, Issue 1, 2018, Page 47-49
Anaplastic thyroid carcinoma; Volume 14, Issue 1, 2018, Page 21-28
Arabic; Volume 12, Issue 2, 2016, Page 31-32
Attitude; Volume 12, Issue 2, 2016, Page 60-63
Awareness; Volume 17, Issue 1, 2021, Page 1-8
B
Beckwith-Wiedemann Syndrome; Volume 18, Issue 2, 2022, Page 81-85
Bilateral; Volume 13, Issue 2, 2017, Page 56-58
Bilateral breast cancer; Volume 15, Issue 1, 2019, Page 1-8
Biological subtypes; Volume 16, Issue 2, 2020, Page 35-41
Bladder cancer; Volume 13, Issue 2, 2017, Page 46-50
Bladder cancer; Volume 14, Issue 2, 2018, Page 83-88
Bladder preservation; Volume 13, Issue 2, 2017, Page 46-50
Body Mass Index; Volume 12, Issue 2, 2016, Page 47-53
Body Mass Index; Volume 12, Issue 2, 2016, Page 54-59
Body Mass Index; Volume 17, Issue 1, 2021, Page 17-22
Body Mass Index; Volume 19, Issue 1, 2023, Page 6-12
Body surface area; Volume 15, Issue 1, 2019, Page 35-37
Bone marrow sparing; Volume 15, Issue 2, 2019, Page 39-45
Bone scan; Volume 12, Issue 1, 2016, Page 20-27
Bone scan; Volume 14, Issue 1, 2018, Page 39-42
Borderline resectable pancreatic cancer; Volume 16, Issue 1, 2020, Page 1-5
Breast; Volume 13, Issue 2, 2017, Page 56-58
Burnout; Volume 15, Issue 1, 2019, Page 26-30
C
Cancer; Volume 12, Issue 2, 2016, Page 31-32
Cancer; Volume 14, Issue 1, 2018, Page 39-42
Cancer; Volume 14, Issue 1, 2018, Page 2-5
Cancer; Volume 17, Issue 1, 2021, Page 17-22
Cancer; Volume 18, Issue 1, 2022, Page 1-9
Cancer Diagnosis; Volume 12, Issue 2, 2016, Page 60-63
Cancer of unknown primary; Volume 18, Issue 2, 2022, Page 69-75
Castleman disease; Volume 19, Issue 1, 2023, Page 13-19
CD4; Volume 18, Issue 2, 2022, Page 45-51
CD56; Volume 16, Issue 1, 2020, Page 6-10
CD8; Volume 18, Issue 2, 2022, Page 45-51
Cervical lymph nodes; Volume 18, Issue 2, 2022, Page 52-60
Chemoradiotherapy; Volume 12, Issue 1, 2016, Page 2-9
Chemoradiotherapy; Volume 14, Issue 1, 2018, Page 29-33
Chemo-radiotherapy; Volume 13, Issue 1, 2017, Page 2-7
Chemotherapy; Volume 12, Issue 2, 2016, Page 47-53
Chemotherapy; Volume 13, Issue 1, 2017, Page 2-7
Chemotherapy; Volume 14, Issue 2, 2018, Page 89-93
Chemotherapy; Volume 15, Issue 1, 2019, Page 35-37
Chest wall irradiation; Volume 15, Issue 1, 2019, Page 1-8
Chordoid; Volume 19, Issue 2, 2023, Page 39-43
Chronic lymphocytic leukemia; Volume 17, Issue 2, 2021, Page 80-85
Cisplatin; Volume 17, Issue 2, 2021, Page 42-50
Clear cell adenocarcinoma; Volume 18, Issue 1, 2022, Page 10-18
Clinical trials; Volume 16, Issue 2, 2020, Page 31-34
Clinical trials; Volume 19, Issue 1, 2023, Page 1-5
Clinicopathological characteristics; Volume 15, Issue 1, 2019, Page 31-34
Colon cancer; Volume 15, Issue 1, 2019, Page 15-19
Colorectal neoplasms; Volume 19, Issue 1, 2023, Page 1-5
Complications; Volume 16, Issue 1, 2020, Page 11-14
Complications; Volume 17, Issue 1, 2021, Page 31-37
Concomitant radiotherapy-chemotherapy; Volume 12, Issue 2, 2016, Page 40-46
Corrigendum; Volume 15, Issue 1, 2019, Page 38-38
Corrigendum; Volume 16, Issue 2, 2020, Page 66-66
Cost-effectiveness; Volume 14, Issue 1, 2018, Page 6-11
Cost-effectiveness; Volume 19, Issue 2, 2023, Page 20-30
COVID-19; Volume 16, Issue 2, 2020, Page 42-47
COVID-19; Volume 17, Issue 2, 2021, Page 80-85
COVID-19; Volume 18, Issue 2, 2022, Page 76-80
C-reactive protein; Volume 14, Issue 2, 2018, Page 83-88
Critical Organ Scoring Index (COSI); Volume 13, Issue 2, 2017, Page 40-45
Cutoff value; Volume 16, Issue 2, 2020, Page 35-41
CyberKnife; Volume 16, Issue 1, 2020, Page 15-21
Cytokine receptor-like factor 2; Volume 17, Issue 1, 2021, Page 23-30
Cytokines; Volume 17, Issue 1, 2021, Page 38-41
Cytokines; Volume 17, Issue 1, 2021, Page 17-22
Cytoplasmic Expression; Volume 16, Issue 2, 2020, Page 48-55
Cytoreductive Surgery; Volume 18, Issue 1, 2022, Page 19-28
D
Degenerative spine disease; Volume 14, Issue 1, 2018, Page 39-42
Denosumab. Giant; Volume 15, Issue 1, 2019, Page 9-14
DIAPH3; Volume 14, Issue 2, 2018, Page 75-82
Diffuse large B-cell lymphoma; Volume 19, Issue 1, 2023, Page 6-12
Disease recurrence; Volume 16, Issue 1, 2020, Page 11-14
Dose distribution; Volume 15, Issue 1, 2019, Page 1-8
Dosimetric; Volume 13, Issue 1, 2017, Page 8-13
Dosimetric evaluation; Volume 13, Issue 2, 2017, Page 40-45
Drug shortage; Volume 15, Issue 1, 2019, Page 15-19
E
Early breast cancer; Volume 16, Issue 2, 2020, Page 35-41
Egypt; Volume 12, Issue 2, 2016, Page 33-39
Egypt; Volume 12, Issue 2, 2016, Page 60-63
Egypt; Volume 13, Issue 1, 2017, Page 14-17
Egypt; Volume 13, Issue 2, 2017, Page 51-55
Egypt; Volume 14, Issue 1, 2018, Page 6-11
Egypt; Volume 15, Issue 1, 2019, Page 26-30
Egypt; Volume 15, Issue 1, 2019, Page 20-25
Egypt; Volume 15, Issue 1, 2019, Page 31-34
Egypt; Volume 16, Issue 2, 2020, Page 42-47
Egypt; Volume 17, Issue 1, 2021, Page 1-8
Egypt; Volume 17, Issue 2, 2021, Page 66-72
Egypt; Volume 17, Issue 2, 2021, Page 51-59
Egypt; Volume 18, Issue 2, 2022, Page 69-75
Egypt; Volume 18, Issue 2, 2022, Page 61-68
Eligibility criteria; Volume 16, Issue 2, 2020, Page 31-34
Encephalopathy; Volume 18, Issue 2, 2022, Page 76-80
Endometrial cancer; Volume 12, Issue 2, 2016, Page 40-46
Endometrial cancer; Volume 14, Issue 2, 2018, Page 59-63
Endometrial cancer; Volume 16, Issue 1, 2020, Page 11-14
Endometrium; Volume 16, Issue 2, 2020, Page 48-55
Ependymoma; Volume 16, Issue 1, 2020, Page 15-21
Epidemiology; Volume 13, Issue 2, 2017, Page 33-39
Epigenetics; Volume 16, Issue 2, 2020, Page 56-65
Epstein Barr virus (EBV); Volume 12, Issue 1, 2016, Page 28-30
Escalated dose; Volume 12, Issue 1, 2016, Page 10-14
ESHAP; Volume 14, Issue 1, 2018, Page 12-16
External beam; Volume 13, Issue 1, 2017, Page 18-22
Extramedullary relapse; Volume 14, Issue 1, 2018, Page 47-49
F
First relapse; Volume 17, Issue 2, 2021, Page 51-59
Flow cytometry; Volume 16, Issue 1, 2020, Page 6-10
FOLFOX; Volume 15, Issue 1, 2019, Page 15-19
Fourth ventricle; Volume 16, Issue 1, 2020, Page 15-21
G
Gastric cancer; Volume 13, Issue 1, 2017, Page 8-13
Gastrointestinal Stromal Tumor; Volume 17, Issue 2, 2021, Page 73-79
Gemcitabine; Volume 17, Issue 2, 2021, Page 42-50
GEMOX; Volume 14, Issue 1, 2018, Page 12-16
Germ cell tumor; Volume 18, Issue 1, 2022, Page 10-18
Glioblastoma Multiforme; Volume 15, Issue 1, 2019, Page 20-25
H
Head and Neck; Volume 16, Issue 1, 2020, Page 22-30
Helical tomotherapy; Volume 15, Issue 1, 2019, Page 1-8
Hemophagocytic lymphohistiocytosis (HLH); Volume 12, Issue 1, 2016, Page 28-30
HER2; Volume 17, Issue 1, 2021, Page 9-16
HER2; Volume 18, Issue 2, 2022, Page 45-51
HER2; Volume 19, Issue 2, 2023, Page 31-38
HER2 positive; Volume 19, Issue 2, 2023, Page 20-30
High-grade; Volume 17, Issue 1, 2021, Page 9-16
High-grade non-Hodgkin lymphoma; Volume 18, Issue 1, 2022, Page 37-44
Hodgkin Lymphoma; Volume 12, Issue 1, 2016, Page 28-30
Hodgkin’s lymphoma; Volume 14, Issue 1, 2018, Page 17-20
Hyperplasia; Volume 16, Issue 2, 2020, Page 48-55
Hyperthermic intraperitoneal chemotherapy; Volume 18, Issue 1, 2022, Page 19-28
Hypofractionated radiotherapy; Volume 15, Issue 2, 2019, Page 46-52
Hypo-fractionation; Volume 13, Issue 1, 2017, Page 18-22
I
Idiopathic; Volume 19, Issue 1, 2023, Page 13-19
IKZF 1; Volume 17, Issue 1, 2021, Page 23-30
IL-10 polymorphism; Volume 17, Issue 1, 2021, Page 17-22
Immunohistochemistry; Volume 19, Issue 2, 2023, Page 31-38
IMRT; Volume 15, Issue 2, 2019, Page 39-45
Intensity-modulated radiation therapy; Volume 12, Issue 1, 2016, Page 10-14
Intensity- modulated radiotherapy (IMRT); Volume 13, Issue 1, 2017, Page 8-13
Interleukin−10; Volume 17, Issue 1, 2021, Page 38-41
Interleukins; Volume 18, Issue 1, 2022, Page 1-9
Intraoperative radiation therapy; Volume 18, Issue 1, 2022, Page 19-28
J
JAK/STAT; Volume 18, Issue 1, 2022, Page 1-9
K
Kasr El-Aini J Clin Oncol Nucl Med 2009; Volume 15, Issue 1, 2019, Page 38-38
Ki-67; Volume 16, Issue 2, 2020, Page 35-41
Kidney function; Volume 16, Issue 2, 2020, Page 31-34
L
Leucovorin; Volume 15, Issue 1, 2019, Page 15-19
Limited resources; Volume 18, Issue 2, 2022, Page 61-68
Lower-income; Volume 16, Issue 2, 2020, Page 42-47
Lymph node ratio; Volume 16, Issue 1, 2020, Page 22-30
Lymph node stage; Volume 16, Issue 1, 2020, Page 22-30
Lymphoid follicles; Volume 19, Issue 2, 2023, Page 39-43
Lymphoid malignancies; Volume 17, Issue 1, 2021, Page 31-37
M
Malignant Pleural Mesothelioma; Volume 14, Issue 1, 2018, Page 6-11
Malignant Pleural Mesothelioma; Volume 14, Issue 2, 2018, Page 50-52
Management; Volume 17, Issue 2, 2021, Page 73-79
Mediastinal lymphadenopathy; Volume 19, Issue 1, 2023, Page 13-19
MEK1; Volume 14, Issue 2, 2018, Page 75-82
Meningioma; Volume 19, Issue 2, 2023, Page 39-43
Metastases; Volume 13, Issue 2, 2017, Page 56-58
Metastatic breast cancer; Volume 14, Issue 2, 2018, Page 64-69
Metastatic cancer; Volume 14, Issue 1, 2018, Page 43-46
Metastatic disease; Volume 14, Issue 2, 2018, Page 70-74
Microsatellite instability; Volume 16, Issue 2, 2020, Page 56-65
MLH1 gene; Volume 16, Issue 2, 2020, Page 56-65
Mucinous adenocarcinoma; Volume 14, Issue 2, 2018, Page 75-82
Multicentric; Volume 19, Issue 1, 2023, Page 13-19
Multiple myeloma; Volume 16, Issue 1, 2020, Page 6-10
Multiple myeloma; Volume 17, Issue 1, 2021, Page 38-41
N
Nanoparticles; Volume 17, Issue 2, 2021, Page 42-50
Neoadjuvant chemoradiotherapy; Volume 16, Issue 2, 2020, Page 56-65
Neoadjuvant chemotherapy; Volume 13, Issue 2, 2017, Page 46-50
Neoadjuvant chemotherapy; Volume 16, Issue 1, 2020, Page 1-5
Neoadjuvant chemotherapy; Volume 17, Issue 2, 2021, Page 60-65
Neonatal Outcome; Volume 14, Issue 2, 2018, Page 89-93
Neopterin; Volume 14, Issue 2, 2018, Page 70-74
Nerve Growth Factor; Volume 14, Issue 2, 2018, Page 53-58
Neurological complications; Volume 18, Issue 1, 2022, Page 29-36
Neuropathy; Volume 14, Issue 2, 2018, Page 53-58
Node-positive; Volume 15, Issue 2, 2019, Page 46-52
Non-Hodgkin’s lymphoma; Volume 14, Issue 1, 2018, Page 17-20
Non-Small Cell Lung Cancer; Volume 12, Issue 1, 2016, Page 15-19
Non-Small Cell Lung Cancer; Volume 12, Issue 2, 2016, Page 33-39
Non-Small Cell Lung Cancer; Volume 13, Issue 1, 2017, Page 23-27
Non-Small Cell Lung Cancer; Volume 17, Issue 2, 2021, Page 42-50
O
Obesity; Volume 14, Issue 1, 2018, Page 39-42
Obesity; Volume 14, Issue 1, 2018, Page 2-5
Obesity; Volume 16, Issue 1, 2020, Page 11-14
Oncologists; Volume 15, Issue 1, 2019, Page 26-30
Organ at risk; Volume 13, Issue 2, 2017, Page 40-45
Outcome; Volume 18, Issue 2, 2022, Page 61-68
Ovarian; Volume 17, Issue 1, 2021, Page 9-16
Ovarian carcinoma; Volume 12, Issue 2, 2016, Page 54-59
P
Paclitaxel; Volume 14, Issue 2, 2018, Page 53-58
Pain; Volume 13, Issue 2, 2017, Page 28-32
Pain; Volume 14, Issue 1, 2018, Page 43-46
Palliative Care; Volume 13, Issue 2, 2017, Page 51-55
Pancreatic adenocarcinoma; Volume 13, Issue 2, 2017, Page 33-39
Pancreatic carcinoma; Volume 13, Issue 1, 2017, Page 2-7
Pancreatic duct adenocarcinoma; Volume 19, Issue 2, 2023, Page 31-38
Papillary thyroid carcinoma; Volume 18, Issue 2, 2022, Page 52-60
Partial hydatidiform mole; Volume 18, Issue 2, 2022, Page 81-85
Patent blue dye; Volume 17, Issue 2, 2021, Page 60-65
Patient-reported outcomes; Volume 12, Issue 2, 2016, Page 31-32
Pediatric; Volume 16, Issue 1, 2020, Page 15-21
Pediatric; Volume 18, Issue 1, 2022, Page 29-36
Pediatric; Volume 18, Issue 1, 2022, Page 10-18
Pediatric; Volume 18, Issue 2, 2022, Page 61-68
Pelvic bone marrow; Volume 15, Issue 2, 2019, Page 39-45
Pemetrexed; Volume 14, Issue 2, 2018, Page 50-52
Performance status; Volume 13, Issue 2, 2017, Page 51-55
Performance status; Volume 14, Issue 1, 2018, Page 43-46
Performance status; Volume 17, Issue 1, 2021, Page 17-22
Perineural invasion; Volume 19, Issue 2, 2023, Page 31-38
Perioperative algorithm; Volume 14, Issue 2, 2018, Page 59-63
Peritoneal sarcomatosis; Volume 18, Issue 1, 2022, Page 19-28
Pharmacokinetics; Volume 15, Issue 1, 2019, Page 35-37
Phyllodes tumor; Volume 13, Issue 2, 2017, Page 56-58
Placental mesenchymal dysplasia; Volume 18, Issue 2, 2022, Page 81-85
Platelet volume/platelet count ratio; Volume 12, Issue 1, 2016, Page 15-19
Practice change; Volume 16, Issue 2, 2020, Page 42-47
Pregnancy associated breast cancer; Volume 14, Issue 2, 2018, Page 89-93
Procedure tract metastasis; Volume 13, Issue 2, 2017, Page 28-32
Prognostic factors; Volume 14, Issue 2, 2018, Page 64-69
Prognostic factors; Volume 17, Issue 2, 2021, Page 51-59
Prognostic factors; Volume 18, Issue 2, 2022, Page 69-75
Prostate Cancer; Volume 12, Issue 1, 2016, Page 10-14
Prostate Cancer; Volume 15, Issue 2, 2019, Page 39-45
Q
R
Radiation; Volume 13, Issue 1, 2017, Page 18-22
Radiological assessment; Volume 16, Issue 1, 2020, Page 1-5
Radiotherapy; Volume 13, Issue 2, 2017, Page 28-32
Radiotherapy; Volume 15, Issue 2, 2019, Page 39-45
Radiotherapy planning; Volume 13, Issue 2, 2017, Page 40-45
RECIST criteria; Volume 16, Issue 1, 2020, Page 1-5
Rectal Cancer; Volume 16, Issue 2, 2020, Page 56-65
Recurrent head and neck cancer; Volume 12, Issue 1, 2016, Page 2-9
Refractory; Volume 14, Issue 1, 2018, Page 17-20
Reirradiation; Volume 12, Issue 1, 2016, Page 2-9
Relapsed; Volume 14, Issue 1, 2018, Page 17-20
Relapsed/refractory lymphoma; Volume 14, Issue 1, 2018, Page 12-16
Res Oncol; Volume 16, Issue 2, 2020, Page 66-66
Resource-limited setting; Volume 19, Issue 2, 2023, Page 20-30
Response to chemotherapy; Volume 14, Issue 2, 2018, Page 83-88
Rhabdomyosarcoma; Volume 18, Issue 1, 2022, Page 10-18
Rituximab; Volume 19, Issue 1, 2023, Page 13-19
S
SARS-CoV-2; Volume 17, Issue 2, 2021, Page 80-85
Schistosomiasis; Volume 13, Issue 1, 2017, Page 14-17
Screening; Volume 17, Issue 1, 2021, Page 1-8
Second-Line Chemotherapy; Volume 13, Issue 1, 2017, Page 23-27
Sentinel lymph nodes; Volume 14, Issue 2, 2018, Page 59-63
Serous Carcinoma; Volume 17, Issue 1, 2021, Page 9-16
Skeletal metastases; Volume 12, Issue 1, 2016, Page 20-27
Skip metastasis; Volume 18, Issue 2, 2022, Page 52-60
SOCS3; Volume 18, Issue 1, 2022, Page 1-9
South Africa; Volume 19, Issue 1, 2023, Page 1-5
Squamous cell carcinoma; Volume 16, Issue 1, 2020, Page 22-30
Stage I; Volume 14, Issue 2, 2018, Page 59-63
Surgery; Volume 16, Issue 1, 2020, Page 11-14
Survival; Volume 12, Issue 2, 2016, Page 54-59
Survival; Volume 13, Issue 2, 2017, Page 33-39
Survival; Volume 16, Issue 1, 2020, Page 11-14
Survival; Volume 17, Issue 2, 2021, Page 51-59
Survival; Volume 18, Issue 2, 2022, Page 69-75
Symptom burden; Volume 13, Issue 2, 2017, Page 51-55
T
Testicular germ cell tumors; Volume 17, Issue 2, 2021, Page 66-72
TFAP2E gene; Volume 16, Issue 2, 2020, Page 56-65
Thermo-luminescent dosimeters; Volume 14, Issue 1, 2018, Page 34-38
Three-dimensional conformal radiotherapy (3D-CRT); Volume 13, Issue 1, 2017, Page 8-13
TMA; Volume 14, Issue 2, 2018, Page 75-82
Trastuzumab dose; Volume 19, Issue 2, 2023, Page 20-30
Treatment; Volume 17, Issue 2, 2021, Page 66-72
Treatment; Volume 18, Issue 1, 2022, Page 29-36
Treatment Planning System; Volume 14, Issue 1, 2018, Page 34-38
Triple-negative breast cancer; Volume 15, Issue 1, 2019, Page 31-34
Tucatinib; Volume 16, Issue 2, 2020, Page 31-34
Tumor burden; Volume 17, Issue 1, 2021, Page 38-41
Tumor-infiltrating lymphocytes; Volume 18, Issue 2, 2022, Page 45-51
U
Upper Egypt; Volume 13, Issue 2, 2017, Page 46-50
Upper Egypt; Volume 18, Issue 1, 2022, Page 29-36
Urinary Bladder Cancer; Volume 13, Issue 1, 2017, Page 14-17
Uro-oncology; Volume 13, Issue 2, 2017, Page 46-50
V
Vagina; Volume 18, Issue 1, 2022, Page 10-18
Visceral metastases; Volume 18, Issue 2, 2022, Page 45-51
VMAT; Volume 15, Issue 2, 2019, Page 39-45
Volumetric modulated arc therapy; Volume 16, Issue 1, 2020, Page 15-21
W
Whole brain radiation; Volume 12, Issue 2, 2016, Page 33-39
X
Y
Z